Here are 11 observations:
1. The market will likely surpass $53 billion by 2024.
2. An increasing geriatric population is boosting the number of arthritis and osteoporosis cases, which will spur orthopedic devices market growth. The growing popularity of minimally invasive surgery and biodegradable implants will also boost market growth.
3. Surgery and device costs as well as unfavorable reimbursements will work against market growth.
4. The joint reconstruction device segment is witnessing growth, fueled by the growing demand for minimally invasive techniques.
5. The trauma fixation device segment will also grow due to the geriatric population suffering bone disorders and fractures.
6. Orthobiologics will likely surpass $4 billion by 2024, due to increasing surgeon popularity of bone grafts and substitutes.
7. In 2016, the U.S. orthopedic devices market reached $20 billion.
8. The U.K. captured more than 15 percent of Europe’s orthopedic devices market share.
9. Japan’s market accounted for more than 40 percent of the region’s market, and will likely surpass $2 billion by 2024.
10. Mexico’s market was worth more than $300 million in 2016, and is expected to grow.
11. Key market players include Medtronic, Stryker, Zimmer Biomet, ConforMIS, DJO Global, MicroPort Scientific Corp., NuVasive, Medacta, Globus Medical, Smith & Nephew and DePuy Synthes.
More articles on devices:
TransEnterix submits additional information for surgical robotic system FDA clearance: 5 insights
Dr. Asif Ilyas completes 1st surgery using Globus Medical’s trauma fixation system: 5 takeaways
NuVasive, DePuy Synthes, Zimmer Biomet & more: 10 device company notes
